Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Shahram Mashouf"'
Autor:
Shahram Mashouf
In this work a nonlinear CW ultrasound field propagation model based on a second-order operator splitting approach is studied and a number of significant enhancements are introduced and implemented. In this model the ultrasound field is calculated an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134c9c8008bbab3994ed454fce8498dd
https://doi.org/10.32920/ryerson.14652231
https://doi.org/10.32920/ryerson.14652231
Autor:
Ali S. Meigooni, D Han, A Soliman, Shahram Mashouf, Amir Owrangi, Habib Safigholi, William Y. Song
Publikováno v:
Medical Physics. 44:6538-6547
Purpose To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR brachytherapy sources, for various cervical cancer high-risk clinical target volumes (CTVHR). Mater
Autor:
David A. Jaffray, Shahram Mashouf, Raymond M. Reilly, Eli Lechtman, Yijie Lu, Zhongli Cai, Jean Philippe Pignol, Priscilla Lai, Mitchell A. Winnik
Publikováno v:
Physics in Medicine and Biology, 62(22), 8581-8599. IOP Publishing Ltd.
Permanent seed implantation (PSI) brachytherapy is a highly conformal form of radiation therapy but is challenged with dose inhomogeneity due to its utilization of low energy radiation sources. Gold nanoparticles (AuNP) conjugated with electron emitt
Publikováno v:
International Journal of Pharmaceutics, 515(1-2), 729-739. Elsevier
We report the design of a nanoparticle depot (NPD) system for local delivery of gold nanoparticles (AuNP) that facilitates their controlled release and is implantable into tumors by permanent seed implantation (PSI) brachytherapy techniques. Various
Autor:
Ananth Ravi, Shahram Mashouf, Tomás Merino, Gerard Morton, William Y. Song, A Soliman, Habib Safigholi
Publikováno v:
Brachytherapy. 15:774-779
Purpose There is strong evidence relating postimplant dosimetry for low-dose-rate prostate seed brachytherapy to local control rates. The delineation of the prostate on CT images, however, represents a challenge due to the lack of soft-tissue contras
Autor:
Tomás Merino, Claire McCann, Priscilla Lai, Emmanuelle Fleury, Shahram Mashouf, Eli Lechtman, Alex Kiss, Jean-Philippe Pignol
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 94(4), 816-823. Elsevier Inc.
Purpose The inhomogeneity correction factor (ICF) method provides heterogeneity correction for the fast calculation TG43 formalism in seed brachytherapy. This study compared ICF-corrected plans to their standard TG43 counterparts, looking at their ca
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 45(1)
Two commonly used treatment planning systems (TPS) are compared for the planning of spine stereotactic body radiotherapy (SBRT). The main purpose is to highlight relative advantages and disadvantages of each system and propose a methodologic approach
Autor:
Priscilla, Lai, Zhongli, Cai, Jean-Philippe, Pignol, Eli, Lechtman, Shahram, Mashouf, Yijie, Lu, Mitchell A, Winnik, David A, Jaffray, Raymond M, Reilly
Publikováno v:
Physics in medicine and biology. 62(22)
Permanent seed implantation (PSI) brachytherapy is a highly conformal form of radiation therapy but is challenged with dose inhomogeneity due to its utilization of low energy radiation sources. Gold nanoparticles (AuNP) conjugated with electron emitt
Autor:
Habib, Safigholi, Dae Yup, Han, Shahram, Mashouf, Abraam, Soliman, Ali S, Meigooni, Amir, Owrangi, William Y, Song
Publikováno v:
Medical physics. 44(12)
To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator usingThe novel DMBT tandem applicator has six peripheral grooves of 1.3-mm diameter along a 5.4-mm thick nonmagnetic tungsten alloy rod. Mon
Autor:
Priscilla Lai, David J. Beachey, Shahram Mashouf, Aliaksandr Karotki, Eli Lechtman, Jean-Philippe Pignol, Brian Keller
Publikováno v:
Physics in Medicine and Biology. 59:5305-5316
Permanent seed implant brachytherapy is currently used for adjuvant radiotherapy of early stage prostate and breast cancer patients. The current standard for calculation of dose around brachytherapy sources is based on the AAPM TG-43 formalism, which